COVID-19 may yield a variety of clinical pictures, differing from pneumonitis to Acute Respiratory Distress Syndrome along with vascular damage in the lung tissue, named endotheliitis. To date, no specific treatment strategy was approved for the prevention or treatment of COVID-19 in terms of endotheliitis-related comorbidities. Here, we presented our treatment strategies for 11 190 COVID-19 patients depending on categorisation by the severity of both the respiratory and vascular distress and presented the manifestations of endotheliitis in skin, lung and brain tissues according to the different phases of COVID-19.

中文翻译：

---

内皮炎在 COVID-19 中的作用：11190 名患者的真实经验和临床分类病理生理图的文献综述

COVID-19 可能会产生多种临床症状，从肺炎到急性呼吸窘迫综合征以及肺组织血管损伤，称为内皮炎。迄今为止，就内皮炎相关合并症而言，尚未批准用于预防或治疗 COVID-19 的具体治疗策略。在这里，我们根据呼吸和血管窘迫的严重程度进行分类，介绍了我们对 11190 名 COVID-19 患者的治疗策略，并根据 COVID-19 的不同阶段介绍了皮肤、肺和脑组织中内皮炎的表现。